Handelsbanken Fonder’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.3M Sell
107,255
-29,207
-21% -$8.81M 0.09% 186
2026
Q1
$45.2M Buy
136,462
+277
+0.2% +$94.3K 0.15% 118
2025
Q4
$54.2M Sell
136,185
-19,184
-12% -$8.49M 0.16% 114
2025
Q3
$70.8M Buy
155,369
+7
+0% +$2.85K 0.23% 86
2025
Q2
$50.7M Buy
155,362
+38,679
+33% +$10.7M 0.18% 112
2025
Q1
$31.5M Buy
116,683
+62,337
+115% +$16M 0.13% 155
2024
Q4
$12.8M Sell
54,346
-18,835
-26% -$4.95M 0.05% 322
2024
Q3
$20.1M Buy
73,181
+130
+0.2% +$33.8K 0.08% 230
2024
Q2
$17.8M Sell
73,051
-2,055
-3% -$324K 0.08% 228
2024
Q1
$11.2M Buy
75,106
+208
+0.3% +$34.7K 0.05% 332
2023
Q4
$14.3M Sell
74,898
-94,845
-56% -$16.2M 0.07% 265
2023
Q3
$30.1M Buy
169,743
+99
+0.1% +$18.9K 0.17% 138
2023
Q2
$32.2M Sell
169,644
-1,645
-1% -$326K 0.17% 135
2023
Q1
$34.3M Sell
171,289
-21,005
-11% -$4.42M 0.2% 120
2022
Q4
$45.7M Buy
192,294
+64,701
+51% +$13.8M 0.29% 81
2022
Q3
$25.5M Sell
127,593
-44,407
-26% -$8.47M 0.17% 149
2022
Q2
$25.1M Buy
172,000
+600
+0.4% +$85.1K 0.16% 147
2022
Q1
$28M Sell
171,400
-16,400
-9% -$2.5M 0.16% 148
2021
Q4
$31.8M Buy
187,800
+167,700
+834% +$31.2M 0.16% 147
2021
Q3
$3.79M Buy
20,100
+1,000
+5% +$188K 0.02% 515
2021
Q2
$3.24M Sell
19,100
-1,200
-6% -$176K 0.02% 544
2021
Q1
$2.87M Sell
20,300
-1,400
-6% -$211K 0.02% 539
2020
Q4
$2.82M Buy
21,700
+2,500
+13% +$334K 0.02% 531
2020
Q3
$2.8M Hold
19,200
0.02% 486
2020
Q2
$2.84M Buy
+19,200
New +$2.59M 0.02% 451
2016
Q1
Sell
-6,348
Closed -$598K 249
2015
Q4
$598K Buy
+6,348
New +$589K 0.01% 600

Other funds holding ALNY